Page 4 - Philip Conaghan News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Research to be presented on Orencia, deucravacitinib and pipeline assets highlights breadth of data and focus on transforming treatment paradigms for people living with rheumatic diseases Bristol Myers Squibb today announced data from 29 company-sponsored presentations across Orencia, deucravacitinib and pipeline assets will be presented at the American College of Rheumatology Convergence 2021, taking place ...

Steve Backshall was diagnosed with Osteoarthritis which affects around a third of people in the UK aged 45 and over. It happened after his stint on Strictly Come Dancing.

Share this article PALO ALTO, Calif., May 5, 2021 /PRNewswire/ --  Genascence Corporation, a clinical-stage biotechnology company developing life-changing gene therapy products for prevalent musculoskeletal diseases, today announced that dosing across all three cohorts has been completed in the Phase 1 clinical trial of GNSC-001 for the treatment of osteoarthritis (OA). GNSC-001 is an adeno-associated vector (AAV) carrying a coding sequence for interleukin-1 receptor antagonist (IL-1Ra), a potent inhibitor of interleukin-1 (IL-1) signaling. IL-1 is considered one of the key mediators involve...

An injection of jelly could help treat worn-out joints. Scientists hope the jab, using jelly found in donated umbilical cords, will stimulate the growth of cushioning cartilage once injected into the knees of patients with osteoarthritis. Tests on animals suggest the jelly — called Wharton’s jelly — can potentially reverse damage to joints caused by the condition. A trial of 12 patients will test its effect in humans. Around nine million people in the UK have osteoarthritis, where cartilage breaks down, meaning bones rub together, causing inflammation and pain. The main cause is ageing,...